1. Natural Product-Inspired Anticancer Drug Discovery

Discovering new anticancer leads from structurally unique natural products and their derivatives.

2. Targeted Protein Degradation

Developing PROTACs and small-molecule degraders based on natural-product ligands and privileged drug scaffolds.

3. Scaffold Hopping & Molecular Editing

Creating new drug-like molecular frameworks through scaffold hopping, bioisosteric replacement, and selective skeletal editing.

4. Asymmetric Catalysis & Innovative Synthesis

Developing selective catalytic and synthetic methods to support the rapid construction of chiral drug molecules and complex bioactive compounds.